I've led scientific content strategy at Merck for the LITESPARK-022 FDA approval, developing an approval content suite spanning a medical information letter, slide decks, verbal response document, medical initiated email, and infographic.
Across Merck's GI, GU, and cross-tumor oncology portfolio, I've developed and maintained 60+ global scientific resources across 40 clinical trials. I synthesize clinical evidence, publications, congress data, regulatory documents, and prescribing information into accurate, balanced content, and lead cross-functional reviews through Veeva Vault MedComms workflows.
My earlier Merck rotations included oncology, infectious disease, and vaccines, where I created medical information letters, healthcare-professional education materials, and oncology slide decks. I also evaluated internal generative AI for scientific content supporting ASCO and ESMO congresses and presented the findings to Global Medical & Scientific Affairs stakeholders.
I'm a PharmD graduate with clinical hospital pharmacy experience, research experience in psychosocial interventions for pregnant women with opioid use disorders, and fluency in English, Spanish, and Italian.
